Biopreservation Market Size, Share & Trends Analysis Report By Product (Equipment, Media, Laboratory Information Management System (LIMS)), By Application (Regenerative Medicine, Bio-Banking, Drug Discovery) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Biopreservation Market Size

The global biopreservation market size was valued at USD 4.46 billion in 2025 and is projected to grow from USD 5.73 billion in 2026 to USD 42.61 billion by 2034, registering a CAGR of 28.5% during the forecast period from 2026 to 2034. North America dominated the biopreservation market with a market share of 41.2% in 2025.

Biopreservation keeps biological samples, cells, tissues, or organs stable to maintain their integrity, viability, and functionality over time. This preservation is critical for many applications in science, medicine, and biotechnology, such as biobanking, drug discovery, regenerative medicine, and transplantation. Biopreservation procedures often employ specialized storage settings, such as low temperatures (cryopreservation), chemical additives (cryoprotectants), or controlled environments (hypothermic storage), to prevent degradation, cell death, or microbiological contamination.

The global biopreservation market growth is primarily driven by the public's increased interest in personalized treatment. Furthermore, governments, academic institutions, and private organizations are expanding their spending on research and development (R&D) activities in life sciences, biotechnology, and healthcare, helping drive the market. Furthermore, as people's knowledge and comprehension of uncommon diseases and genetic abnormalities grew, there was a greater need to conserve biological samples from those affected. These techniques enable the collecting and preserving of these samples to understand disease causes, create diagnostics, and accelerate the development of tailored medicines, contributing to worldwide needs.

Furthermore, the development of improved cryoprotectants, automated systems, and enhanced storage protocols is broadening the capabilities and applications of biopreservation by ensuring the efficiency, dependability, and safety of preserved biological materials, resulting in a buoyant market outlook.

Product Insights

The equipment sector had the largest market share of 70% in 2023, owing to an increased need for bio-banking to preserve stem cells, DNA, plasma, and tissue culture. Biopreservation equipment is a collection of apparatus and tools to store, handle, and treat biological samples. This includes ultra-low-temperature freezers, cryogenic storage tanks, automated sample handling systems, and thawing equipment. Ultra-low temperature freezers keep samples below -80°C, or even -150°C, assuring long-term preservation.

Cryogenic storage tanks use liquid nitrogen or other cryoprotectants to keep samples at extremely low temperatures for long periods. Automated sample handling systems simplify sample preparation, inventory management, and retrieval, improving efficiency and integrity. Thawing devices allow for the quick and controlled thawing of cryopreserved materials while minimizing cell damage. The widespread adoption and use of preservation has benefited from substantial storage capacity and minimal maintenance, which is projected to drive the industry.

The media segment has the potential to expand because it is an essential component of the biopreservation process. Biopreservation media are specific formulations that protect cells, tissues, and organs throughout storage and transit. These media contain cryoprotectants, antioxidants, osmotic agents, and buffering components to keep cells alive and functional. Cryopreservation media reduce ice crystal formation, osmotic stress, and cellular damage during freezing and thawing.

Moreover, media apps provide more features and details, allowing researchers to access and share research data and analysis, enhancing their ability to explore, diagnose, monitor, and treat health issues. This tendency is expected to fuel market expansion throughout the forecast period.

Request Customizationto receive a tailored report.

Application Insights

The biobanking category dominated the global market, accounting for 75%. Biobanking is collecting, processing, storing, and disseminating biological specimens for research, clinical trials, and demographic studies, such as blood, serum, plasma, tissues, and genetic materials. Biobanks store a wide range of human samples and data, allowing researchers to study illness molecular pathways, identify biomarkers, and develop new diagnostics and therapies. Biopreservation technologies assure biobank samples' long-term stability and integrity, preserving their molecular signatures and clinical utility. Biobanks serve various purposes, including cancer research, pharmacogenomics, epidemiology, and customized treatment.

Additionally, stem cell preservation is gaining popularity, as is sperm and egg banking and assisted reproductive technology with animals. Pharmaceutical corporations collaborate with reserve biobanks and hospitals to preserve tissues.

The regenerative medicine category is predicted to develop at a higher CAGR over the forecast period due to rising demand for technologically sophisticated bio-storage techniques. Biopreservation is crucial in regenerative medicine because it preserves cells, tissues, and bioengineered constructions employed in therapeutic applications. Stem cells, progenitor cells, and tissue-engineered grafts are kept under controlled conditions in regenerative medicine to ensure their viability, functioning, and potency. These preserved materials are helpful for cell-based therapeutics, tissue engineering, and organ regeneration. In addition, introducing specific preservation procedures is projected to drive category growth in the following years.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global biopreservation market shareholder and is estimated to grow at a CAGR of 28.2% over the forecast period. North America generated the most revenue in the biopreservation market, accounting for 40% of the total. The North American market is primarily driven by an increase in demand for the preservation of blood, solid tissue specimens, including paraffin-embedded or frozen tumor biospecimens, and other tissues (such as peripheral blood cells, bone marrow, and stem cell-derived cord blood and its derivatives) across multiple research institutes, pathological centers, and hospitals.

Furthermore, the increased government investment in drug development is expected to increase the utility of biopreservation for the ex-vivo preservation of cells, tissues, and organs for storage, shipment, and transportation purposes. For example, the Canadian government funded USD 45 million in the Stem Cell Network this year and for the next three years to promote stem cell and regenerative medicine research. Such expenditures are expected to increase the usefulness and demand for biopreservation in the region, driving market expansion during the forecast period.

Additionally, technological developments, increased product approvals, alliances, and acquisitions by important companies all contribute to market expansion. For example, in February 2022, OriGen Biomedical Inc., a global medical device manufacturer of cryopreservation, cell culture, and respiratory devices, introduced the CryoStore FLEX Freezing Bag in the United States and Europe. The CryoStore FLEX Bag is intended for the cryopreservation of blood components and provides multi-chamber flexibility for small-volume dosage solutions.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Biopreservation Market Trends

Asia-Pacific is anticipated to exhibit a CAGR of 28.8% over the forecast period due to increased financing support for biobanking techniques and services and expanded partnerships and collaborations based on biopreservation methods. According to a January 2023 study based on the Longitudinal Ageing Study in India (LASI), 32.1% of older individuals in India have many morbidities, compared to 30.3% who had only one. As a result of the increasing prevalence of chronic diseases in the country, the region's biopreservation industry will rise in the future. Increased hospital use and the massive construction of new biobanks are driving the expansion of the biopreservation market.

Europe is likely the most appealing section of the market over the forecast period. Germany is expected to see the fastest growth in Europe throughout the forecast period due to increased funding support for biobanking techniques and services and increased partnerships and collaborations from bio-preservation approaches. Increased government financing for biobank networking, such as the UK Biobank, and international alliances to expand biobanking's reach have rapidly expanded the biopreservation sector.

Latin America might also emerge as an essential income hub. Government assistance for research and development is expected to increase the acceptability of bio-storage and drive regional market growth. The Latin American biopreservation market will expand significantly throughout the forecast period.

The Middle East and Africa market is predicted to have a minor proportion of the global biopreservation market due to an underdeveloped healthcare sector, a lack of technological understanding, and inadequate medical facilities.

List of Key and Emerging Players in Biopreservation Market